1672-3384
2017 Issue 1
Characteristics of novel anticoagulants marketed in China and the development of their clinical application
YOU Guo-jiao;,DU Li-ping;,CHEN Yue-xin;,MEI Dan;
YOU Guo-jiao;,DU Li-ping;,CHEN Yue-xin;,MEI Dan;
..............page:1-7
Progress on antidepressants
LI Yue;,HE Min;,ZHANG Lei-yang;,QIU Fu-rong;,CHEN Wen-wen;,WU Yu;,YANG Jiang-wei;,JIANG Jian;
LI Yue;,HE Min;,ZHANG Lei-yang;,QIU Fu-rong;,CHEN Wen-wen;,WU Yu;,YANG Jiang-wei;,JIANG Jian;
..............page:8-13
Gene oriented individualized therapy
LIU Zhi-yan;,YANG Bing;,ZHAO Rong-sheng;
LIU Zhi-yan;,YANG Bing;,ZHAO Rong-sheng;
..............page:14-20
Analysis of reasonability of clinical use of folk medicine in the Third affiliated hospital of Beijing university of Chinese medicine
LU Shu;,HAN Fei;,KONG Xiang-wen;,LI Bo;,YU Jing-yuan;,WANG Yu-guang;,CAO Jun-ling;
LU Shu;,HAN Fei;,KONG Xiang-wen;,LI Bo;,YU Jing-yuan;,WANG Yu-guang;,CAO Jun-ling;
..............page:21-24
Efficacy and adverse effect of lenalidomide in relapsed/refractory chronic lymphocytic leukemia patient：a meta-analysis
LIANG Liang;,ZHAO Ming;,ZHU Yuan-chao;,HU Xin;,YANG Li-ping;
LIANG Liang;,ZHAO Ming;,ZHU Yuan-chao;,HU Xin;,YANG Li-ping;
..............page:25-32
Literature review onefficacy and safety of solifenacin and tolterodine
ZOU Yu-zhen;,JIANG Wei-zhe;,ZHAO Lei-lei;,MEI Dan;
ZOU Yu-zhen;,JIANG Wei-zhe;,ZHAO Lei-lei;,MEI Dan;
..............page:33-37
..............page:37-37
Tigecycline combined with cefoperazone sulbactam in the treatment of pneumonia induced by multiple-/extensively drug resistantAcinetobacter baumannii：a meta-analysis
WANG Jia;,LUO Xia;,WANG Lin-hai;,KE Zun-qiong;,HU Xiao;,YU Xu-ming;
WANG Jia;,LUO Xia;,WANG Lin-hai;,KE Zun-qiong;,HU Xiao;,YU Xu-ming;
..............page:38-42
Systematic review on entecavir combined with adefovir dipivoxil for the treatment of lamivudine-resistant chronic hepatitis B (CHB)
LIU Xiu-rong;,DENG Li-ning;,HOU Hong-bo;
LIU Xiu-rong;,DENG Li-ning;,HOU Hong-bo;
..............page:43-47
Pharmaceutical care path design of neuromyelitis optica spectrum disorders
MENG Yao;,ZHOU Ying;,WANG Xiao-ling;,WU Ye;,CUI Yi-min;
MENG Yao;,ZHOU Ying;,WANG Xiao-ling;,WU Ye;,CUI Yi-min;
..............page:48-50
Sevoflurane and propofol for pediatric anesthesia to maintain the effect observation and influence on cerebral oxygen metabolism
ZHANG Min;,XIE Ai-ling;
ZHANG Min;,XIE Ai-ling;
..............page:51-53
Analysis of 19 cases of hemorrhage treated with warfarin consulted by clinical pharmacists
XIE Qiu-fen;,XIANG Qian;,WANG Zi-ning;,HU Kun;,ZHAO Xia;,ZHOU Ying;,CUI Yi-min;
XIE Qiu-fen;,XIANG Qian;,WANG Zi-ning;,HU Kun;,ZHAO Xia;,ZHOU Ying;,CUI Yi-min;
..............page:54-58
Rational medication of hypertension induced by anti-angiogenesis drugs
YUWEN Li-xia;,SHI Hui-hui;,SUN Xin-ye;,YUAN Yao-hui;
YUWEN Li-xia;,SHI Hui-hui;,SUN Xin-ye;,YUAN Yao-hui;
..............page:59-61
Experience of rescuing 4 patients with anaphylactic shock caused by paclitaxel
SANG Die;,ZHANG Yu-rong;,DING Mei-xuan;,LI Yan;,OU Kai-ping;,MA Fei;
SANG Die;,ZHANG Yu-rong;,DING Mei-xuan;,LI Yan;,OU Kai-ping;,MA Fei;
..............page:62-64
Azathioprine induced leukopeniain a patient with TPMT heterozygous mutation genotype
CHEN Di;,HOU Shi-fang;,JIN Yi;,GUO Hong;,YANG Li-ping;
CHEN Di;,HOU Shi-fang;,JIN Yi;,GUO Hong;,YANG Li-ping;
..............page:65-67
Analysis on the participation of clinical pharmacist in the treatment of acute myocardial infarction under pulse indicator continuous cardiac output monitoring
ZHANG Di-fei;,ZOU ming;,FU Ting;,XU Ming-liang;,MAO min;
ZHANG Di-fei;,ZOU ming;,FU Ting;,XU Ming-liang;,MAO min;
..............page:68-70
Sebelipase alfa-- drug to treat lysosomal acid lipase deficiency
SONG Qi;,MA Wei;,LI Qin-yuan;,LIU Min;
SONG Qi;,MA Wei;,LI Qin-yuan;,LIU Min;
..............page:71-74
Reference significance of 18th National essential medicine List of WHO on the essential medicine list, National insurance medicine list of China
NI Qian;,PEI Yi-fang;,FENG Yu-fei;,YANG Li-ping;,HU Xin;
NI Qian;,PEI Yi-fang;,FENG Yu-fei;,YANG Li-ping;,HU Xin;
..............page:75-78
New combination of melanoma treatment:Nivolumab and ipilimumab
ZHANG Min;,ZHONG Wu;
ZHANG Min;,ZHONG Wu;
..............page:79-84
..............page:85-86
ye suan zhi liao ke jiang di huan gao dan gu chun xue zheng de gao xue ya huan zhe shou ci zu zhong feng xian
shi wei long ;
shi wei long ;
..............page:85-85
..............page:86-86
..............page:87-88